Literature DB >> 9126077

Reproduction of functional smooth muscle tissue and partial bladder replacement.

M Probst1, R Dahiya, S Carrier, E A Tanagho.   

Abstract

OBJECTIVE: To find a means of bladder augmentation that would avoid the complications encountered with the use of bowel segments, using a newly developed acellular biomaterial, the bladder acellular matrix graft (BAMG), as a homologous graft.
MATERIALS AND METHODS: Thirty-four rats underwent a partial cystectomy (40-50%) and grafting with a BAMG of equal size. Eleven rats died within the first 72 h. probably from urinary leakage caused by obstruction of the bladder neck with stones or coagula; the surviving 23 were killed at varying intervals after cystectomy and examined.
RESULTS: After providing initial bladder enlargement, the graft was progressively infiltrated by the vessels and smooth muscle cells of the host: furthermore, the mucosal lining was complete within 10 days. After 4 weeks, all bladder wall components were evident histologically in the graft. The ingrowth was complete after 8 weeks, except for neural regeneration, which was only partial. At 12 weeks, the bladder wall muscle structure in the graft was so well developed that it was difficult to delineate the junction between host bladder and BAMG. Neural regeneration continued to improve. Normal bladder capacities were maintained throughout the study.
CONCLUSION: The BAMG appears to serve, without rejection, as a framework of collagen and elastin for the ingrowth of all bladder wall components. The reason for the better acceptance of the BAMG than of other bladder augmentation grafts requires further investigation.

Entities:  

Mesh:

Year:  1997        PMID: 9126077     DOI: 10.1046/j.1464-410x.1997.00103.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  28 in total

1.  Urothelial cell transplantation using biodegradable synthetic scaffolds.

Authors:  S D Scriven; L K Trejdosiewicz; D F Thomas; J Southgate
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

Review 2.  [Acellular matrix for functional reconstruction of the urogenital tract. Special form of "tissue engineering"?].

Authors:  N Schlote; J Wefer; K-D Sievert
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

Review 3.  Tissue engineering and regenerative medicine research perspectives for pediatric surgery.

Authors:  Amulya K Saxena
Journal:  Pediatr Surg Int       Date:  2010-03-24       Impact factor: 1.827

Review 4.  Strategies for organ level tissue engineering.

Authors:  Kristine C Rustad; Michael Sorkin; Benjamin Levi; Michael T Longaker; Geoffrey C Gurtner
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

5.  Tissue engineering in urology.

Authors:  Derek J Matoka; Earl Y Cheng
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

Review 6.  Production of urothelium from pluripotent stem cells for regenerative applications.

Authors:  Stephanie L Osborn; Eric A Kurzrock
Journal:  Curr Urol Rep       Date:  2015-01       Impact factor: 3.092

7.  Bladder reconstruction: The past, present and future.

Authors:  Omar M S El-Taji; Altaf Q Khattak; Syed A Hussain
Journal:  Oncol Lett       Date:  2015-04-28       Impact factor: 2.967

8.  Epithelial-differentiated adipose-derived stem cells seeded bladder acellular matrix grafts for urethral reconstruction: an animal model.

Authors:  Hongbin Li; Yuemin Xu; Hong Xie; Chao Li; Lujie Song; Chao Feng; Qin Zhang; Minkai Xie; Ying Wang; Xiangguo Lv
Journal:  Tissue Eng Part A       Date:  2014-01-17       Impact factor: 3.845

9.  Tissue-engineered cholecyst-derived extracellular matrix: a biomaterial for in vivo autologous bladder muscular wall regeneration.

Authors:  Abdol-Mohammad Kajbafzadeh; Shabnam Sabetkish; Reza Heidari; Maryam Ebadi
Journal:  Pediatr Surg Int       Date:  2014-01-28       Impact factor: 1.827

10.  Acellularization of embryoid bodies via physical disruption methods.

Authors:  Alyssa V Ngangan; Todd C McDevitt
Journal:  Biomaterials       Date:  2008-11-29       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.